A Possible Path towards Prevention

Mihai Nadin*

Vaccination related to the COVID-19 pandemic turned out to be a global experiment. In the absence of clinical studies for assessing safety, dosage, immune response of subjects of different age groups, etc., vaccination as a means of reducing the number of victims practically replaced the final phase of the customary cycle of trials for FDA approval. Given this reality, methods for post-hoc evaluation need to be designed. This would serve as guidance for future preventive measures.

Keywords:

Published on: Nov 22, 2024 Pages: 54-56

Full Text PDF Full Text HTML DOI: 10.17352/asb.000024
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat